Spyre Therapeutics (SYRE) Cash & Equivalents (2015 - 2026)
Spyre Therapeutics (SYRE) reported Cash & Equivalents of $162.01 million for Q2 2026, up 98.4% from $81.66 million a year earlier and up 66.7% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics posted Cash & Equivalents of $85.72 million, down 4.1% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $89.42 million in FY2024 (-52.7%), $188.89 million in FY2023 (+441.8%), $34.86 million in FY2022 (+130.2%) and $15.14 million in FY2021 (-83.2%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q1 2024.
- Year over year, Cash & Equivalents gained in three of the last eight quarters, with growth averaging 14.2%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2024 (growth of 545.7%); the low point was Q4 2021 (a decline of 83.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $97.19 million (Q1 2026), $85.72 million (Q4 2025) and $64.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Spyre Therapeutics | 8.21 Bn | 8.21 Bn | - | 162.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162.01 Mn |
| Mar 31, 2026 | 97.19 Mn |
| Dec 31, 2025 | 85.72 Mn |
| Sep 30, 2025 | 64.90 Mn |
| Jun 30, 2025 | 81.66 Mn |
| Mar 31, 2025 | 48.49 Mn |
| Dec 31, 2024 | 89.42 Mn |
| Sep 30, 2024 | 71.58 Mn |
| Jun 30, 2024 | 45.14 Mn |
| Mar 31, 2024 | 227.55 Mn |
| Dec 31, 2023 | 188.89 Mn |
| Sep 30, 2023 | 90.59 Mn |
| Jun 30, 2023 | 235.36 Mn |
| Mar 31, 2023 | 35.24 Mn |
| Dec 31, 2022 | 34.86 Mn |
| Sep 30, 2022 | 38.99 Mn |
| Jun 30, 2022 | 37.47 Mn |
| Mar 31, 2022 | 14.64 Mn |
| Dec 31, 2021 | 15.14 Mn |
| Sep 30, 2021 | 24.67 Mn |
API Access
Spyre Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();